TGF-beta1 gene silencing for treating liver fibrosis (Q42215330)

18 October 2017

TGF-beta1 gene silencing for treating liver fibrosis (English)

1 reference

18 October 2017

0 references

Kun Cheng

1

1 reference

18 October 2017

Ningning Yang

series ordinal

2

1 reference

18 October 2017

Ram I Mahato

series ordinal

3

1 reference

18 October 2017

language of work or name

English

0 references

publication date

1 May 2009

1 reference

18 October 2017

Molecular Pharmaceutics

1 reference

18 October 2017

6

1 reference

18 October 2017

3

1 reference

18 October 2017

772-779

1 reference

Structural and formulation factors influencing pyridinium lipid-based gene transfer.

18 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

How can transforming growth factor beta be targeted usefully to combat liver fibrosis?

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Regulation of alpha1(I) collagen messenger RNA decay by interactions with alphaCP at the 3'-untranslated region

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Deaths: final data for 2001.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Cirrhosis: new research provides a basis for rational and targeted treatments

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Liver fibrosis -- from bench to bedside

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Roles of TGF-beta in hepatic fibrosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

TGFbeta1 in liver fibrosis: time to change paradigms?

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

A new mathematical model for relative quantification in real-time RT-PCR

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Fas / FasL system, IL-1beta expression and apoptosis in chronic HBV and HCV liver disease.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Engagement of alphavbeta3 integrin regulates proliferation and apoptosis of hepatic stellate cells

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2743970

RNA interference targeting Fas protects mice from fulminant hepatitis

17 August 2018

1 reference

12 December 2020

[Effect of small interfering RNA targeting connective tissue growth factor on the synthesis and secretion of extracellular matrix in hepatic stellate cells]

1 reference

12 December 2020

Growth factor and procollagen type I gene expression in human liver disease

1 reference

12 December 2020

Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1

1 reference

12 December 2020

Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis

1 reference

12 December 2020

The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis

1 reference

12 December 2020

siRNA pool targeting different sites of human hepatitis B surface antigen efficiently inhibits HBV infection

1 reference

12 December 2020

Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C

1 reference

12 December 2020

Identifiers

DOI

10.1021/MP9000469

1 reference

18 October 2017

1 reference

18 October 2017

1 reference